ATHN CV

Enter your search criteria to find works by title, author, publication, keyword(s), or date.

Back

ATHN 16

Insight into ATHN 16: Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors to Evaluate the Safety of Coagulation Factor VIIa (recombinant)-jncw

Author(s):

Tammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, Lauren Amos, Daniel Bonzo, Meera Chitlur, Miguel Escobar, Ahley Eason, Carol Fedor, Shveta Gupta, Philip Kurikose, Emmanuelle Lagrue, Matthew Manuel, Sonia Nasr, Sharon Pennington, Rajiv Pruthi, Doris Quon, Michael Recht, Mark Reding, Spencer Sullivan, Allison Wheeler
Publication:
Thrombosis & Hemostasis Summit of North America (THSNA) 2024
Date:
April 4-6, 2024
Topics:
ATHN 16, hemophilia A, hemophilia B, inhibitors, factor VIIa (recombinant)-jncw
Visit Publication

Preliminary Analysis of ATHN 16: Real-World Safety of Eptacog Beta

Author(s):

Lauren Amos, Daniel Bonzo, Ashley Eason, Miguel Escobar, Christine Knoll, Philip Kurikose, Emmanuelle Lagrue, Sonia Nasr, Michael Recht, Spencer Sullivan, Doris Quon, Mark Reding
Publication:
ISTH 2023 Congress (poster)
Date:
June 24-28, 2023
Topics:
Hemophilia, Safety
Visit Publication

A Preliminary Analysis of ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors

Author(s):

Tammuella Chrisentery-Singleton, Lauren E Amos, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Emmanuelle Lagrue, Christine Knoll, Sonia Nasr, Michael Recht, Spencer Sullivan, Doris V Quon, Mark T Reding
Publication:
Blood
Date:
November 15, 2022
Topics:
Safety, Eptacog-Beta
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Tammuella Chrisentery-Singleton, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael U Callaghan, Miguel Escobar, Adam Giermasz, M Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris V Quon, Mark Reding, Michael Recht
Publication:
Thrombosis & Hemostasis Summit of North American 2022
Date:
August 17, 2022
Topics:
Adult treatments, AHP including (AIP)
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors, with or without Prophylactic Treatment

Author(s):

Tammuella Christenery-Singleton, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael Callaghan, Miguel Escobar, Adam Giermasz, M Nikki Hirsh, Janna Journeycake, Sonia Nasr, Rajiv Pruthi, Doris Quon, Amina Rafique, Mark Reding, Spencer Sullivan, Michael Recht
Publication:
ISTH 2022 Congress
Date:
July 9-13, 2022
Topics:
Safety, Eptacog-Beta
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Michael Callaghan, W Allen Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Miguel Escobar, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris Quon, Tammuella Chrisentery-Singleton, Michael Recht
Publication:
Haemophilia
Date:
July 1, 2022
Topics:
Safety, Eptacog-Beta
Visit Publication

PO035 ATHN 16: Safety of Coagulation Factor VIIA (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Tammuella Chrisentery-Singleton, W Allan Alexander, Ahmad Al-Sabbagh, Miguel Escobar, Adam Giermasz, Janna Journeycake, Sonia Nasr, Doris Quon, Michael Recht, Daniel Bonzo, M Nikki Hirsh, Mark Reding, Michael Callaghan
Publication:
15th Annual Congress of EAHAD Virtual
Date:
February 2-4, 2022
Topics:
Chromogenic Method, Factor VIII, Antibody, Emicizumab
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Congenital Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Tammuella Chrisentery-Singleton, W Allen Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Michael U Callaghan, Miguel Escobar, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris V Quon, Michael Recht
Publication:
Blood
Date:
November 5, 2021
Topics:
Bleeding Events, Inhibitors, Prophylactic Treatment
Visit Publication

Safety of Coagulation Factor 7A (recombinant) for the Treatment of Bleeding Events in Patients with Hemophilia A or B

Author(s):

Nikki Hirsh, Janna Journeycake, Doris Quon, Tammuella Chrisentery-Singleton, Michael Recht
Publication:
HTRS 2021 Scientific Symposium
Date:
March 10-12, 2021
Topics:
Visit Publication

ATHN 16: Safety of Coagulation Factor VIIa (recombinant)-Jncw for the Treatment of Bleeding Events in Patients with Hemophilia A or B with Inhibitors with or without Prophylactic Treatment

Author(s):

Michael Callaghan, W Allan Alexander, Ahmad Al-Sabbagh, Daniel Bonzo, Adam Giermasz, Nikki Hirsh, Janna Journeycake, Sonia Nasr, Doris Quon, Tammuella Chrisentery-Singleton, Michael Recht
Publication:
HTRS 2021 Scientific Symposium
Date:
March 10-12, 2021
Topics:
Scientific, Symposium, Virtual Conf. (2021)
Visit Publication

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.